chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 6 year old female who in approximately 2001 at approximately 15 months of age, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient developed chickenpox on her head, neck and underarms. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Rash, Stress
Clinical narrative: Information has been received from a mother concerning her approximately 1-year-old daughter with no medical history or allergies who, at 1-year-old, was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck). There was no concomitant therapy. The patient's mother reported that, a couple months after receiving the varicella virus vaccine live (Oka/Merck), her daughter developed a shingles rash on her right thigh which spread downward. Unspecified medical attention was sought and the patient was prescribed a steroid medication which seemed to clear the rash in about a week. No laboratory/diagnostic tests were performed. The patient's mother indicated that her daughter has been fine since the initial rash, except on a few occasions when her daughter was feeling a little stressed she began to get what seemed to be the rash again. The mother also indicated that the rash went away when her daughter's stress went away. At the time of this report, the patient was noted to be fine. Additional information has been requested.
Age: 1.01
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a physician concerning a 7 year old male who on 23-FEB-2000 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot # "1460J09'). On approximately 04-NOV-2006 the patient started to develop lesions and presented to the physician's office on 06-NOV-2006 with over one hundred lesions. No further information was available. There was no product quality complaint involved. Additional information has been requested. 02/11/2010 Follow up information received froma licensed practical nurse indicated that on 06-NOV-2006 the patient was diagnosed with chickenpox on his back, head, buttocks and groin. It was reported that the patient had greater than 100 lesions on his back. There were no lab tests performed. The patient was treated with (ATARAX) 2 teaspoons orally pm ever 8 hours for 10 days. On 16-NOV-2006 the patient recoverd. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Body temperature, Cough, Erythema, Nasal congestion
Clinical narrative: Information has been received from a registered nurse concerning an 8-year-old female with a peanut allergy and a history of wheezing who on 26-FEB-1999 was vaccinated in the left thigh with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 628147/1262H). The patient had cold symptoms at the time of the vaccination. Concomitant therapy included albuterol. On 01-NOV-2006, the patient developed less than 50 vesicles that were itchy over her whole body. On 04-NOV-2006 the patient was seen in the doctor's office, the vesicles were red and some were crusted over (also reported as "2 itchy quarter sized welts with central pimples on her back,"She was afebrile but did  continue to have a stuffy nose and cough. Symptomatic treatment included diphenhydramine (BENADRYL) and an unspecified anti-itch lotion, transmission precautions were also advised. On an unspecified date the patient recovered. No additional information to report. There were no lab diagnostic studies performed. There was no product quality complaint. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus
Clinical narrative: Information has been received from a registered nurse concerning an 8-year-old female with a peanut allergy and a history of wheezing who on 26-FEB-1999 was vaccinated in the left thigh with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 628147/1262H). The patient had cold symptoms at the time of the vaccination. Concomitant therapy included albuterol. On 01-NOV-2006, the patient developed less than 50 vesicles that were itchy over her whole body. On 04-NOV-2006 the patient was seen in the doctor's office, the vesicles were red and some were crusted over (also reported as "2 itchy quarter sized welts with central pimples on her back,"She was afebrile but did  continue to have a stuffy nose and cough. Symptomatic treatment included diphenhydramine (BENADRYL) and an unspecified anti-itch lotion, transmission precautions were also advised. On an unspecified date the patient recovered. No additional information to report. There were no lab diagnostic studies performed. There was no product quality complaint. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 16-month-old biracial female with a sulfonamide allergy who on 16-JUN-2006 was vaccinated subcutaneously in the left leg with a first dose of Varivax (lot# 652727/0428F). There was no illness at the time of vaccination. On 26-OCT-2006 the patient experienced chickenpox "despite immunization." No medical attention was sought and no laboratory or diagnostic tests were performed. No outcomes were reported. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Malaise, Pyrexia, Rash pruritic
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 4-year-old male with no medical history and allergies who on 24-JUN-2003 was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot# 641161/0796M).  Concomitant therapy included loratadine (CLARITIN) and was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Winstar RA 27/3) (manufacturer unknown) on 24-JUN-2003. On 05-NOV-2006 the patient developed an itchy rash with fever and malaise. Unspecified medical treatment was sought, no laboratory or diagnostic treatments were performed. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an 80-year-old female who "within the past week", approximately 01-NOV-2006 was vaccinated subcutaneously with a dose of varicella virus vaccine live (Ork/Merck). It was reported that the patient should have received a dose of varicella-zoster virus vaccine live (MSD) instead of the varicella virus vaccine live (Oka/Merck). Unspecified medical attention was sought. The R.N. reported that there was no reaction to this. No product quality complaint was involved. Additional information is not expected, the reporter could not be contacted.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning an 18 month old female who at 12 months of age was vaccinated with a 0.5 mL dose of Varivax. Subsequently, at the age of 18 months of age she developed shingles. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARCEL
Symptoms: No adverse reaction, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning an 80 year old female who on 03-NOV-2006 was vaccinated with a dose of Varivax instead of varicella-zoster virus vaccine. It was reported that this was not a product confusion issue, but new staff employee error. Unspecified medical attention was sought. The patient has not experienced any adverse reaction. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 70 year old female who on 18-NOV-2006 was vaccinated with a dose of Varivax instead of a dose of Zostavax. There was no product quality complaint involved Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a female nurse who on an unspecified date was vaccinated with a dose of Varivax. Subsequently the patient developed shingles. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug exposure during pregnancy, Haemorrhage
Clinical narrative: Information has been received through the Merck pregnancy registry from a 26-year-old female with hyperthyroidism and no drug reactions/allergies who on 19-JUNE-2006 was vaccinated with a dose of varicella virus vaccine live (Ork/Merck). Concomitant therapy included levothyroxine sodium (SYNTHROID). It was noted that the patient was pregnant (LMP=approximately 04-JUL-2006). In July 2006, the patient experienced a little bleeding through the first month which has since stopped. Unspecified medical attention was sought. No further information provided. There was no product quality complaint. No additional information is expected.
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a male who two years ago, in 2004, was vaccinated with a first dose of varicella virus live vaccine (Oka/Merck). Subsequently, the patient experienced a shingles-like symptoms and a rash. Unspecified medical attention was sought. Subsequently, the patient recovered. No product quality complaint was involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a female who was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed a rash. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning his 7-year-old daughter with asthma and a history of hepatitis A, who at one year of age, on approximately 30-NOV-1999, was vaccinated with a dose of Varivax. On 01-OCT-2006 the patient developed "bumps under her arm" which was diagnosed as breakthrough chickenpox. Unspecified medical attention was sought and she was treated with acyclovir. No diagnostic or laboratory studies were performed. Subsequently, the patient recovered from breakthrough chickenpox. No product quality complaint was involved. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Exfoliative rash, Rash erythematous, Rash papular, Skin lesion
Clinical narrative: Information has been received from a physician concerning a 10 year old female with no past medical history, who on 12-OCT-2006 was vaccinated with a second dose of Varivax. There was no concomitant medication. On 15-OCT-2006 (also reported as 25-OCT-2006) the patient developed a desquamating rash in a "saddle-like" distribution in her inguinal/vaginal area which worsened over time. The number of lesions was unknown and at the time of the report the rash was resolving in this area after treatment with CALAMINE LOTION. Subsequently the patient developed new vesicles on the shoulder in an approximately 2X4 region, with 5 "tiny" vesicles, raised, papular, and erythematous. Unspecified medical attention was sought. The patient was otherwise well and without a fever. No other symptoms were reported. There was no product quality complaint involved. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: DTAPH, MMR, OPV, VARCEL
Symptoms: No reaction on previous exposure to drug, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning her daughter a 9 year old female with no medical history or allergies who on 24-MAR-1998 was vaccinated with a first dose of Varivax (lot # 620642/1340D). Concomitant therapy included a third dose of poliovirus vaccine oral # 0769K/448498), a first dose of MMR II (lot # 622264/0596E) and a fourth dose of TriHIBit (lot # 0875900). On 15-MAY-2006 the patient developed varicella. She broke out in over 400 chickenpox. Medical attention was not sought. The patient recovered on 25-MAY-2006. It was reported that the patient nor her siblings ever experienced an adverse event following prior vaccination. The patient's vaccination history included the following: a first, second, and third dose of TriHIBit on 25-FEB-1997 (lot # 429-968), 29-APR-1997 (lot #438-621) and 08-JUL-1997 (lot # 438-621); a first dose of DTaP on 03-APR-2001 (lot # U0317AB); a first and second dose of hepatitis A virus vaccine in activated on 16-FEB-1999 (lot # 627922/1444H) and 21-SEP-1999 (lot # 632776/1148J); a first, second and third dose of hepatitis B virus vaccine on 24-DEC-1996, 25-FEB-1997 (lot # 620761/1308D) and 08-JUL-1997 (lot # 622477/0071E); a first dose of poliovirus vaccine inactivated (unspecified) on 03-APR02991 (lot# T0485-2); a second dose of MMR II (lot # 632236/0937J) on 03-APR-2001; a first and second dose of poliovirus vaccine (lot # 0747K/438118) on 25-FEB-1997 and 29-APR-1997; a first dose of Trivalent Flu (VFC) (lot # U1268AA) on 10-NOV-2003. Additional information is not expected.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician (D.O.) concerning a 30-year-old who on 10-JUL-2006 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). Six weeks later, In August 2006, the patient experience a negative titer. On 21-AUG-2006, the patient was vaccinated with a second dose of varicella virus vaccine live (Ork/Merck). In November 2006, the patient again experience a negative titer. Subsequently, the patient did not experience any symptoms. Unspecified medical attention was sought. It was reported that the patient did not recover from the negative titer. no product quality compliant was involved. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning an approximately 8-year-old male who was vaccinated with a 0.5mL dose of varicella virus vaccine live (Oka/Merck). Subsequently, on approximately 06-NOV-2006, the patient experienced breakthrough and had about 15 to 20 lesions. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Crohn's disease
Clinical narrative: Information has been received from a physician concerning her daughter with no drug reaction/allergies who on 07-AUG-1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There were no concomitant medications. In June 2006, the patient was diagnosed with Crohn's disease. She has been receiving prednisone and azathioprine sodium (IMURAN) for the treatment of Crohn's disease. In October 2006, the patient showed a negative varicella zoster virus titer. Unspecified medical attention was sought. There was no product quality compliant. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 7-year-old male with no pre-existing allergies, birth defects, or medical conditions who on 05-OCT-2000 at 11:30AM was vaccinated SC in the left upper arm with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 632726/0088K). There was no illness at the time of vaccination. On 13-NOV-2006 in the AM, the patient developed a rash on his face and underarm along with a low grade fever. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 44-month-old female who on 08-JUN-2004 was vaccinated SC in the right leg with a first dose of Varivax (Lot # 641710/04252N). Concomitant therapy that day included a first dose of MMR II (Lot # 644707/0040P) administered SC in the left leg. On 26-OCT-2006 the patient experienced breakthrough chickenpox. Subsequently, the patient recovered from chickenpox on 06-NOV-2006. Unspecified medical attention was sought. Additional information has been requested.
Age: 85.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Varicella
Clinical narrative: Information has been received from a physician and a registered nurse (R.N.) concerning a 5-year-old female with no pre-existing allergies, birth defects, or medical conditions, who on 25-JUL-2006 at 10:00 was vaccinated subcutaneously with a second dose of Varivax (lot# 646538/0783R). There was no illness at the time of vaccination. On 19-AUG-2006 the patient developed chickenpox. Unspecified medical attention was sought and the chicken pox were described as moderate to severe and the size of an eraser tip with hard whit pustules. They started on the patient's trunk and moved to the ankles, arms, legs, arm pits, and vaginal area. The patient also experienced a low grade temperature. No laboratory or diagnostic tests were performed. Subsequently, the patient recovered from chickenpox on 25-AUG-2006. No product quality complaint was involved. Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site discomfort, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse practitioner (NP) concerning a 14-year-old female with no medical history or allergies who on 13-NOV-2006 was vaccinated SC in the right arm with the first 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (Lot #650388/0914R). There was no concomitant therapy. The NP reported 15-NOV-2006, the patient developed a 3-4 inch area if redness, swelling, warmth and discomfort at injection site of her right arm. On that same day, the patient was examined and ice compresses and ibuprofen were prescribed. No laboratory/diagnostic tests were performed. Follow-up appointments were scheduled for 16-NOV-2006 and 17-NOV-2006. At that time of this report, the patient's events persisted. Additional information has been requested.
Age: 0.1
Sex: M
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Varicella
Clinical narrative: Information has been received from a physician concerning a male with no medical history or allergies who in 2001 was vaccinated with the first 0.5 mL dose of Varivax. There was no concomitantly therapy. The physician reported that the patient subsequently developed a case of breakthrough chickenpox. Unspecified medical attention was sought. No laboratory/diagnostic tests were provided. At the time of this report, the outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from the physician concerning a 6-year-old male with no pre-existing allergies, birth defects, or medical conditions who on 22-NOV-2004 was vaccinated subcutaneously in the right thigh with a first dose of varicella virus vaccine live (Oka/Merck) (lot# reported as "0649F"). There was no illness at the time of vaccination. On 03-NOV-2006 the patient experienced a rash on his trunk, arms and legs for 5 days. Subsequently, the patient recovered on 08-NOV-2006. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 35-month-old female with no pre-existing allergies, birth defects, or medical conditions who on 22-NOV-2004 was vaccinated subcutaneously with a first dose of Varivax (Lot # 649444/0649P). On 03-NOV-2006, the patient experienced a rash on her trunk, arms and legs. There were no relevant laboratory or diagnostic data. On 08-NOV-2006, the patient recovered. There were no adverse events following prior vaccinations of the patient or her siblings. There was no illness at the time of vaccination. No additional information to report. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 4-year-old overweight female with a history of a streptoccal infection who on 23-JUN-2006 was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (Lot #643768/1063M). The RN reported that on 14-NOV-2006, the patient developed breakthrough chickenpox characterized by 50-249 lesions on her face, back, neck,chest, abdomen and right wrist. The vesicles were also noted to be on the roof of her mouth. Unspecified medical attention was sought and the patient was ordered diphendramine HCL (BENEDRYL), cool compresses and acyclovir. As of 16-NOV-2006, the patient was recovering as she was noted to be doing better. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician's assistant concerning a 14-year-old female who was vaccinated SC with a 0.5mL dose of Varivax. In approximately 2005 the patient developed a rash and was diagnosed with shingles. Unspecified medical attention was sought. Subsequently, in approximately 2005, the patient recovered. There was no product quality complaint. No additional information is expected.
Age: 20.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning a 20 year old female nursing student who was part of a study, who on unspecified dates in 1992 was vaccinated with a first and second dose of Varivax. on 16-NOV-2006 the patient was found to have a low or negative titer. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient developed chickenpox. It was unknown if medical attention was sought. The patient's outcome was not reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with his/her first 0.5 mL dose of Varivax. Subsequently the patient developed shingle-like symptoms. Unspecified medical attention was sought. The patient's outcome was not reported. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a 17-month-old white female with no known pre-existing allergies, birth defects, or medical conditions who on 19-JUN-2006 was vaccinated SC with the first dose of varicella virus vaccine live (Oka/Merck) (lot # 652629/1031R). There was no illness at the time of the vaccination. Concomitant therapy that day included a first dose of measles-mumps-rubella vaccine (MSD) (Lot # 653338/0216F) administered SC and a forth dose of pneumococcal 4 6B 9V 18C 19F 23F conj vaccine (CRM197) (PREVNAR) (Batch # B06641A) administered IM. On 16-NOV-2006 the patient developed a rash with less than 50 lesions. Subsequently, the patient recovered. It was noted that the patient's father had shingles. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 7 year old black male with no medical history or allergies who on 17-OCT-2000 at 17:15 was vaccinated a SC first dose of with varicella virus vaccine live (Oka/Merck) (lot # 636565/0922K). There was no concomitant medication. There was no illness at the time if vaccination. On 03-NOV-2006 at 10:05 the a diagnosed of chickenpox was made while the patient was seen in the office. No laboratory tests were performed. The patient's outcome was unknown. There was no product quality compliant involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: FLU3, MMR, VARCEL
Symptoms: Blister, Body temperature, Erythema, Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old female with no allergies or medical conditions who on 06-OCT-2006 was vaccinated SC in the right thigh with a first dose of varicella virus vaccine live (Oka/Merck) (lot # 652666/0248F). Concomitant vaccination on the same day included a SC first does in the left thigh of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Winstar RA 27/3) (MSD) (lot # 650753/0971R), and an IM first dose on the right thigh of influenza virus splint virion 3v vaccine inactivated (FLUZONE) (lot # U2A8AA). There was no illness at the time of vaccination. On 06-NOV-2006, the patient was seen in the office and noted to have 50-75 scattered, red, raised papules on both legs. A few looked vesicular. She was afebrile. No diagnostic laboratory tests were performed. The patient recovered on 08-NOV-2006. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical assistant concerning her daughter, about 6 years old who had been sick with a cold, who in late August 2006, was vaccinated with "one dose" of varicella virus vaccine live (Oka/Merck). On 02-NOV-2006 the child broke out in "pocs" on her back and trunk, but "not so much" on her extremities. The mother reported her daughter had greater than 50 "pocs". At the time of this report the child was reportedly recovering and "crusting over". Unspecified medical attention was sought. There was no product quality compliant. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/16/2007. Additional information has been received from the child's physician who reports that the vaccine was not administered at the office and there is no record of a report of adverse reaction at the office. No further information is avilable.
Age: 9.0
Sex: M
Vaccine: FLUX, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 9-year-old male (brother 1 of 2) with seasonal allergies and amoxicillin allergy who on 17-NOV-2006 was vaccinated SC with a 0.5 mL dose of Varivax (Lot # 652450/0948R). Concomitant therapy included ALLEGRA. On 19-NOV-2006 the patient experienced a six-inch raised red sore area around injection site and sore area around the injection site. Unspecified medical attention was sought; treatment included TYLENOL and ice. No diagnostic studies were performed. NO additional information to report. There was no product quality complaint involved. It was also noted that the patient's brother was also vaccinated with Varivax on 17-NOV-2006 and experienced a raised red sore area around injection site and sore area around the injection site (WAES # 0611USA06138). Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: FLUX, VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Information has been received from a registered nurse concerning a 10-year-old male with seasonal allergies and amoxicillin allergy who on 17-NOV-2006 was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot # 652450/0948R). Concomitant therapy that day in the other arm included influenza virus vaccine (unspecified). Other concomitant therapy included unnamed nasal sprays and eye drops for allergies. On 19-NOV-2006, the patient experience a six-inch raised red sore area around the varicella virus vaccine live (Oka/Merck) injection site. Medical attention was sought; treatment included ice and acetaminophen (TYLENOL). No additional information to report. There were no lab diagnostic studies performed. There is no product quality compliant. It was also noted that the patient's brother was also vaccinated with varicella virus vaccine live (Oka/Merck) and experienced a six-inch raised red sore area around the injection site (WAES #0611USA06125). Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with a second dose of Varivax. Subsequently, the patient "had a reaction to the second dose of Varivax", unspecified medical attention was sought. The patient experienced pain and redness at the injection site. The patient also "developed a knot at the injection site." No fever was reported and the reaction lasted as "few days." There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Rash maculo-papular, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male, with no medical history and no allergies, who on 08-SEP-1999 was vaccinated with Varivax (Merck). There was no illness at the time of vaccination. There was no concomitant medication. On 14-NOV-2006 the patient developed 30-35 "maculopapular lesions vesicular" on the hair line, trunk, groin, arms, and legs. The patient sought medical attention. Treatment included diphenhydramine (Benadryl) and another unspecified therapy. No diagnostic laboratory tests were performed. Subsequently, the patient recovered. Additional information has been requested. No further informtion is epxected.
Age: 38.0
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a 38 year old patient who in February 2006 finished the Varivax series. Subsequently the patient had a titer value of 0.68. It was reported that a value of less than 0.91 is considered negative. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Sex: U
Vaccine: FLUX, VARCEL
Symptoms: Erythema, Oedema peripheral, Pyrexia
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a 0.5 ml dose of Varivax (lot# 654530/1046F). Concomitant therapy included a dose of  influenza virus vaccine (unspecified). Subsequently, the patient experienced a red, swollen arm and a fever. Unspecified medical attention was sought. At the time of this report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4-year-old child who on 26-DEC-2002 was vaccinated with a dose of Varivax (Lot # 641783/0262M). Subsequently, on 20-NOV-2006, the patient experienced chickenpox. The outcome was not recovered. No other information was provided. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning an 8 year old female who on 11-JAN-1999, at 3:00 p.m., was vaccinated with a subcutaneous first dose Varivax (Lot# 628246/1655H). It was reported that the patient's mother called into the office to report chickenpox symptoms beginning on 20-NOV-2006. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a certified medical assistant (C.M.A.) concerning a 6-year-old male with a history of mild lymphoid hyperplasia and no allergies, who on 25-APR-2001 was vaccinated subcutaneously in the left arm with one dose of Varivax (lot # reported as "1574K") and "1314K"). Concomitant vaccination included a dose of MMR II (lot# 631048/0105K) given subcutaneously in his right arm and the patient also had Tubersol (lot# C0999AA) given intradermally in the right forearm. There was no illness at the time of vaccination. On 27-NOV-2006, after the child was exposed at school, the patient developed chickenpox, characterized by 15-20 eruptions on his face, trunk, arms and legs. Unspecified medical treatment was sought and the patient was treated with diphenhydramine hydrochloride (Benadryl). No laboratory or diagnostic tests were performed. At the time of this report the patient had recovered. No product quality complaint was involved. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no history of drug reactions and no pertinent medical history who on 16-SEP-2002, was vaccinated with Varivax. Concomitant therapy included montelukast sodium (MSD). On 29-NOV-2006, the patient experienced full blown case of chickenpox. The child had 50 lesions and a temperature of 100.7F. She was treated with acyclovir (ZOVIRAX). Unspecified medical attention was sought. No lab studies were performed. As of 29-NOV-2006, the patient's full blown case of chickenpox persisted. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with Varivax. On 29-NOV-2006, the physician reported that "recently", the patient developed breakthrough chicken pox after receiving one dose of Varivax. The time frame between vaccination and break through was unspecified. Unspecified medical attention was sought. The breakthrough was recent and the physician reported that the child is recovering and that the lesions were crusted over. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Pityriasis lichenoides et varioliformis acuta, Skin lesion
Clinical narrative: Information has been received from a physician concerning a 4 year old patient who on 29-JAN-2004 was vaccinated with a first 0.5 ml dose of Varivax (Merck). Subsequently the patient experienced breakthrough. The lesions had lasted approximately three weeks and the patient was still experiencing breakouts. It was unknown how many lesions the child experienced. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested. Additional information has been received from the physician who reported that the patient had pityriasis lichenoides et varioliformis acuta(PLEVA) and not varicella. No further information is available.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 4-year-old male with no pertinent medical history and no allergies, who on 25-JUL-2003 was vaccinated subcutaneously with a 0.5 ml first dose of Varivax (lot# 644091/1066M). There was no illness at the time of vaccination. There was no concomitant medication. On 29-NOV-2006, the patient developed vesicular lesions to the face and trunk and was diagnosed with a mild case of varicella. Unspecified medical attention was sought. No laboratory or diagnostic tests were performed. At the time of this report the patient had recovered as of 05-DEC-2006. No product quality complaint was involved. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 15-month-old male who in August 2006 (at the age of 12 months), was vaccinated with Varivax. In November 2006, three months after vaccination, the patient experienced a shingles outbreak. Unspecified medical attention was sought. No additional information is available. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Nasopharyngitis, Pyrexia, Varicella
Clinical narrative: Information has been received from a certified medical assistant concerning a 12 year old female who in 1999 (as reported by her father) was vaccinated with a dose of Varivax. On 29-NOV-2006 the patient was seen in the office with a chickenpox rash. It was reported that the patient had about 30 rashes with different stages. It was reported that the rash started after a few days of fever and cold symptoms. No diagnostic lab tests were performed. It was also reported that her brother had chickenpox 2-3 weeks before the patient. The patient's recovery status was unknown. No other information was available. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis diaper
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male who on 27-NOV-2006 or 28-NOV-2006 was vaccinated with a first dose of Varivax. On 29-NOV-2006 or 30-NOV-2006 the patient developed diaper rash. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is available.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 6-year-old male who on 08-FEB-2002 was vaccinated with a first dose of Varivax. There was no illness at the time of vaccination. On 19-NOV-2006 the patient developed a rash on his back, neck, and trunk with less than 50 lesions. He was seen in the office on 21-NOV-2006. The patient recovered on 29-NOV-2006. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: FLUX, MMR, PNC, VARCEL
Symptoms: Erythema, Herpes zoster, Rash
Clinical narrative: Information has been received from a licensed visiting nurse (L.V.N.) concerning a 13-month-old female with a slight heart murmur who on 20-NOV-2006 at 10:00 was vaccinated subcutaneously with a 0.5 ml first dose of Varivax (lot# 654524/1042F). Concomitant vaccinations given on 20-NOV-2006 included: a dose of MMR II (lot# 654820/1027F) (MSD), a fourth dose of Prevnar given intramuscularly and a dose of influenza virus vaccine (unspecified). On 30-NOV-2006 at 11:30 the patient experienced a rash with clusters and erythema on her face and under the chin on her right side only. On 04-DEC-2006 she was seen in the physician's office and had small little clusters on her chin, her face and under her ear. The physician diagnosed her with shingles. No laboratory or diagnostic studies were performed. She was treated with calamine and calamine (+) camphor (+) pramoxine hydrochloride (AVEENO lotion). She recovered as of 06-DEC-2006. The VZVID program was offered. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Abdominal pain upper, Herpes simplex, Herpes zoster, Pain in extremity
Clinical narrative: Information has been received from a licensed practical nurse concerning a 4-year-old female with no pertinent medical history and no history of drug reaction/allergies who on 26-SEP-2003 was vaccinated subcutaneously with a dose of Varivax (645578/0439N). There were no concomitant medications. On 01-DEC-2006, the patient experienced confirmed zoster. It was reported that the rash developed on the mid upper back and spread to her left shoulder and back of her left arm, and that there were some small spots on her chest. The patient also experienced a painful arm and stomach pain. Unspecified medical attention was sought. A TZANCK prep was obtained. VZV analysis by polymerase chain reaction was offered but refused. The patient status was reported as recovering. No additional information to report. Additional information has been requested.
Age: 83.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning an 83 year old female who in approximately November 2006 was vaccinated with a dose of Varivax instead of a dose of Zostavax. The medical assistant reported that this was "office staff error only". The patient did not experience any adverse events post vaccination. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 14 year old female, with no medical history, who on 06-DEC-2006 was vaccinated with a second intramuscular dose in the right arm of Varivax (Lot# 655065/1142F). Concomitant vaccine administered on the same day included a first dose in the right arm of Gardasil (Lot# "0916F"). It was reported that, on 06-DEC-2006, the patient's injection site swelled to the size of a golf ball, and had become red and tender but developed no fever. The patient was treated with ice. At the time of the report the patient was recovering. There were no laboratory diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: VARCEL
Symptoms: Anti-HBs antibody negative, Hepatitis B e antigen negative
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 41-year-old female with no pertinent medical history or allergies, who in the 1990's was vaccinated with two doses of Varivax. On 30-NOV-2006 the patient had a titer done that came back negative. Unspecified medical attention was sought. Subsequently, the patient experienced no symptoms. No product quality complaint was involved. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Medication error, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7-year-old male with attention deficit/hyperactivity disorder, allergy to milk protein and fluconazole (DIFLUCAN) who on 08-MAR-2000 was vaccinated with an inflammatory dose of Varivax (Lot number possibly "14640" but not the nurse was not sure because the "o" was unclear). On 04-DEC-2006, the patient experienced breakthrough chicken pox; he had less than 50 lesions. Medical attention was sought and he was treated with acyclovir 400 mg once a day for five days. No laboratory or diagnostic tests were performed. The outcome was recovering at the time of the laboratory or diagnostic tests were performed. The outcome was recovering at the time of the report. No further information to report. There was no product quality complaint involved. No additional information is expected.
Age: 27.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a nurse concerning a 27 year old female, with no pertinent medical history, drug reactions or allergies, who on 25-NOV-2006 was vaccinated with Varivax. Subsequently the patient developed lesions, which were first noticed on 09-DEC-2006. Upon examination the nurse practitioner noticed the patient had five lesions, and the patient mentioned getting new ones. The lesions that first appeared were still vesicular and had not crusted over at the time of this report. The patient was prescribed acyclovir (ZOVIRAX) 800 mg, 5 times a day for 5 to 7 day, along with oatmeal baths and an antihistamine for the itching. No further information is available. Medical attention was sought. There were no lab diagnostic studies performed. The outcome was not recovered. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an approximately 4 year old female, with no pertinent medical history, drug reactions or allergies, who on 23-JUN-2003 was vaccinated with "one dose" of Varivax and subsequently developed a mild case of chickenpox with an onset of 10-DEC-2006. The patient presented to the office on 11-DEC-2006, with several dozen lesions that were either fluid filled or scabbed. The patient's mother reported on 12-DEC-2006, the fluid filled lesions from the day before had crusted over, but new ones had developed. The patient did not experience any itchiness, and was not uncomfortable, and therefore no treatment was prescribed. The patient had not yet recovered at the time of this report. There was no concomitant therapy. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 1.22
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash maculo-papular, Skin lesion
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 5 year old male, with a history of failure to thrive (FTT) at nine months of age, and no reported drug reactions or allergies, who on 15-APR-2002 he was vaccinated subcutaneously with 0.5 mcg of Varivax (Merck) (lot number 640491/0973L). On 12-DEC-2006 the patient developed a macular papular rash, approximately 20 lesions, on his abdomen. The patient was afebrile, but complained of itchiness. There was no concomitant medication. The patient had not yet recovered at the time of the report. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. No further information is expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 25-month-old white female with no pertinent medical history or allergies who on 11-NOV-2006 was vaccinated in the left thigh with the first dose of Varivax (Lot # 654759/1064F). There was no illness at the time of vaccination. There were no pre-existing allergies, birth defects or medical conditions. On 02-DEC-2006, the patient presented to the doctor's office with breakthrough with less than 50 lesions. There were no adverse events following prior vaccination for the patient or siblings. No other problems were noted. NO diagnostic or laboratory tests were performed. On 11-DEC-2006, the patient recovered. No additional information is expected.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with a dose of Varivax instead of Zostavax due to "nurse error". There were no symptoms noted. There was no product quality complaint involved. Additional information has been requested.